09:53 AM EST - Spectral Medical Inc. : Today announced that the U.S. Food & Drug Administration has granted Breakthrough Device designation for the Company’s Toraymyxin device, a therapeutic hemoperfusion device that removes endotoxin, which can cause septic shock. Spectral Medical Inc.
shares T.EDT are trading up $0.10 at $0.45.
